Background Carbapenems are the last line of defence against ever more prevalent MDR
Gram-negative bacteria, but their efficacy is threatened worldwide by bacteria that produce …

Increasing prevalence of carbapenem-resistant Pseudomonas aeruginosa and
Acinetobacter baumannii strains in the nosocomial setting in Latin America represents an …

Acinetobacter baumannii infections have become an emerging health concern in hospitals
across the world and are often associated with nosocomial infections with poorer clinical …

Carbapenem resistance in gram-negative bacteria by production of carbapenemases is one
of the most challenging issues regarding healthcare worldwide. We review the epidemiology …

The aim of this study was to analyze the prevalence of carbapenem resistance genes in
Acinetobacter spp. isolated from wastewater in a municipal WWTP and to determine their …

Acinetobacter baumannii is an emerging hospital pathogen. Whereas A. baumannii isolated
from patients or hospitals has been reported, there are few data regarding propagation of …

Después del desarrollo y la comercialización en masa de los antibióticos, las bacterias
patógenas y ambientales han desa-rrollado resistencia a los antibióticos desde el siglo …

Background: Acinetobacter baumannii is an important human pathogen with increasing
notoriety in the recent years, as a causative organism of drug resistant nosocomial …

Background Acinetobacter baumannii, the first human pathogen to be designated as a" red-
alert" pathogen, is on the critical priority list of pathogens requiring new antibiotics. Biofilm …

Background Nosocomial infections caused by carbapenem-resistant Acinetobacter spp are
a global health problem. The aim of this study was to investigate the molecular epidemiology …